Cullinan Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Cullinan Therapeutics, Inc. has filed 463 SEC EDGAR filings since 02 Nov 2020

SEC filing history

Showing 51-66 of 66 matching filings.

Per page
25
Current page
3
8-K File 001-39856

FORM 8-K

Filing date
30 Mar 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39856

8-K

Filing date
26 Feb 2021
Reporting date
23 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39856

8-K

Filing date
22 Feb 2021
Reporting date
22 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39856

8-K

Filing date
13 Jan 2021
Reporting date
07 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .